D‐Limonene for regulating metabolism‐associated fatty liver disease (MAFLD) and analysis of the TCM constitution: A protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial (DL‐MAFLD‐TCM)

D‐Limonene for regulating metabolism‐associated fatty liver disease (MAFLD) and analysis of the TCM constitution: A protocol for an exploratory, randomized, double‐blind, placebo‐controlled trial (DL‐MAFLD‐TCM)

Abstract The protocol describes the first study evaluating the treatment of metabolism‐associated fatty liver disease (MAFLD). MAFLD, formerly known as nonalcoholic fatty liver disease, was renamed by an internationally renowned liver disease expert group in 2020. MAFLD contains three types: overwei...

Full description

Bibliographic Details
Main Authors: Wenwen Lv, Xiyang Tan, Xiaochen Chen, Tingting Hu, Jiayuan Jiang, Qiang Li, Xiao‐yun Chen, Hongsheng Tan, Biyun Qian
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Food Frontiers
Subjects:
D‐limonene
MAFLD
randomized controlled trial
study protocol
Online Access:https://doi.org/10.1002/fft2.171

Internet

https://doi.org/10.1002/fft2.171

Similar Items